 | • レポートコード：B-GIR08C1146 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、細胞療法・組織工学の世界市場について調べ、まとめました。種類別セグメントは、細胞療法、組織工学等、用途別セグメントは、等に区分しました。細胞療法・組織工学の世界市場概観、企業動向、企業別細胞療法・組織工学シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・細胞療法・組織工学の市場概観 ・細胞療法・組織工学の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・細胞療法・組織工学の企業別販売動向、市場シェア、市場集中度、競争動向 ・細胞療法・組織工学の世界市場規模 ・細胞療法・組織工学の北米市場分析（アメリカ、カナダ、メキシコ等） ・細胞療法・組織工学のアメリカ市場規模推移 ・細胞療法・組織工学のカナダ市場規模推移 ・細胞療法・組織工学のメキシコ市場規模推移 ・細胞療法・組織工学のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・細胞療法・組織工学のドイツ市場規模推移 ・細胞療法・組織工学のイギリス市場規模推移 ・細胞療法・組織工学のロシア市場規模推移 ・細胞療法・組織工学のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・細胞療法・組織工学の日本市場規模推移 ・細胞療法・組織工学の中国市場規模推移 ・細胞療法・組織工学の韓国市場規模推移 ・細胞療法・組織工学のインド市場規模推移 ・細胞療法・組織工学の東南アジア市場規模推移 ・細胞療法・組織工学の南米市場分析（ブラジル、アルゼンチン等） ・細胞療法・組織工学の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・細胞療法・組織工学の種類別分析/販売量、売上、市場シェア（細胞療法、組織工学） ・細胞療法・組織工学の用途別分析/市場規模（） ・細胞療法・組織工学の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・細胞療法・組織工学の販売チャネル・代理店・貿易業者・ディーラー分析 |
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.
Scope of the Report:
Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.
The global Cell Therapy and Tissue Engineering market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Therapy and Tissue Engineering.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cell Therapy and Tissue Engineering market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Therapy and Tissue Engineering market by product type and applications/end industries.
Market Segment by Companies, this report covers
Betalin Therapeutics
BioCardia, Inc
BioReliance Corporation
Biosolution Co., Ltd.
Brainstorm Cell Therapeutics, Inc
MaxCyte, Inc
Medigene AG
MEDIPOST CO., Ltd.
Mesoblast Limited
Miromatrix Medical, Inc.
MolMed S.p.A
Mustang Bio, Inc
NantKwest, Inc.
Neuralstem, Inc
NexImmune, Inc.
Nohla Therapeutics, Inc
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Rubius Therapeutics, Inc.
Sangamo Therapeutics, Inc
Voyager Therapeutics, Inc
Waisman Biomanufacturing
WindMIL Therapeutics, Inc.
Wuxi App Tec, Inc.
ReNeuron Group plc
Richter-Helm BioLogics GmbH & Co. KG
RoosterBio, Inc
RoslinCT
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cell Therapy
Tissue Engineering
Market Segment by Applications, can be divided into
Cell Defects
Genetic Diseases
Neurodegenerative Diseases
Tissue Malignancies
Others
Table of Contents
1 Cell Therapy and Tissue Engineering Market Overview
1.1 Product Overview and Scope of Cell Therapy and Tissue Engineering
1.2 Classification of Cell Therapy and Tissue Engineering by Types
1.2.1 Global Cell Therapy and Tissue Engineering Revenue Comparison by Types (2019-2024)
1.2.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Types in 2018
1.2.3 Cell Therapy
1.2.4 Tissue Engineering
1.3 Global Cell Therapy and Tissue Engineering Market by Application
1.3.1 Global Cell Therapy and Tissue Engineering Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cell Defects
1.3.3 Genetic Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Tissue Malignancies
1.3.6 Others
1.4 Global Cell Therapy and Tissue Engineering Market by Regions
1.4.1 Global Cell Therapy and Tissue Engineering Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.5 Global Market Size of Cell Therapy and Tissue Engineering (2014-2024)
2 Company Profiles
2.1 Betalin Therapeutics
2.1.1 Business Overview
2.1.2 Cell Therapy and Tissue Engineering Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.2 BioCardia, Inc
2.2.1 Business Overview
2.2.2 Cell Therapy and Tissue Engineering Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioReliance Corporation
2.3.1 Business Overview
2.3.2 Cell Therapy and Tissue Engineering Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biosolution Co., Ltd.
2.4.1 Business Overview
2.4.2 Cell Therapy and Tissue Engineering Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.5 Brainstorm Cell Therapeutics, Inc
2.5.1 Business Overview
2.5.2 Cell Therapy and Tissue Engineering Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.6 MaxCyte, Inc
2.6.1 Business Overview
2.6.2 Cell Therapy and Tissue Engineering Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.7 Medigene AG
2.7.1 Business Overview
2.7.2 Cell Therapy and Tissue Engineering Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.8 MEDIPOST CO., Ltd.
2.8.1 Business Overview
2.8.2 Cell Therapy and Tissue Engineering Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.9 Mesoblast Limited
2.9.1 Business Overview
2.9.2 Cell Therapy and Tissue Engineering Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.10 Miromatrix Medical, Inc.
2.10.1 Business Overview
2.10.2 Cell Therapy and Tissue Engineering Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.11 MolMed S.p.A
2.11.1 Business Overview
2.11.2 Cell Therapy and Tissue Engineering Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.12 Mustang Bio, Inc
2.12.1 Business Overview
2.12.2 Cell Therapy and Tissue Engineering Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.13 NantKwest, Inc.
2.13.1 Business Overview
2.13.2 Cell Therapy and Tissue Engineering Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.14 Neuralstem, Inc
2.14.1 Business Overview
2.14.2 Cell Therapy and Tissue Engineering Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.15 NexImmune, Inc.
2.15.1 Business Overview
2.15.2 Cell Therapy and Tissue Engineering Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.16 Nohla Therapeutics, Inc
2.16.1 Business Overview
2.16.2 Cell Therapy and Tissue Engineering Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.17 ReNeuron Group plc
2.17.1 Business Overview
2.17.2 Cell Therapy and Tissue Engineering Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.18 Richter-Helm BioLogics GmbH & Co. KG
2.18.1 Business Overview
2.18.2 Cell Therapy and Tissue Engineering Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.19 RoosterBio, Inc
2.19.1 Business Overview
2.19.2 Cell Therapy and Tissue Engineering Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.20 RoslinCT
2.20.1 Business Overview
2.20.2 Cell Therapy and Tissue Engineering Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.21 Rubius Therapeutics, Inc.
2.21.1 Business Overview
2.21.2 Cell Therapy and Tissue Engineering Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.22 Sangamo Therapeutics, Inc
2.22.1 Business Overview
2.22.2 Cell Therapy and Tissue Engineering Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.23 Voyager Therapeutics, Inc
2.23.1 Business Overview
2.23.2 Cell Therapy and Tissue Engineering Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.24 Waisman Biomanufacturing
2.24.1 Business Overview
2.24.2 Cell Therapy and Tissue Engineering Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.25 WindMIL Therapeutics, Inc.
2.25.1 Business Overview
2.25.2 Cell Therapy and Tissue Engineering Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.26 Wuxi App Tec, Inc.
2.26.1 Business Overview
2.26.2 Cell Therapy and Tissue Engineering Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.27 ReNeuron Group plc
2.27.1 Business Overview
2.27.2 Cell Therapy and Tissue Engineering Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.28 Richter-Helm BioLogics GmbH & Co. KG
2.28.1 Business Overview
2.28.2 Cell Therapy and Tissue Engineering Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.29 RoosterBio, Inc
2.29.1 Business Overview
2.29.2 Cell Therapy and Tissue Engineering Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.30 RoslinCT
2.30.1 Business Overview
2.30.2 Cell Therapy and Tissue Engineering Type and Applications
2.30.2.1 Product A
2.30.2.2 Product B
2.30.3 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cell Therapy and Tissue Engineering Market Competition, by Players
3.1 Global Cell Therapy and Tissue Engineering Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Therapy and Tissue Engineering Players Market Share
3.2.2 Top 10 Cell Therapy and Tissue Engineering Players Market Share
3.3 Market Competition Trend
4 Global Cell Therapy and Tissue Engineering Market Size by Regions
4.1 Global Cell Therapy and Tissue Engineering Revenue and Market Share by Regions
4.2 North America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.3 Europe Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.5 South America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
5 North America Cell Therapy and Tissue Engineering Revenue by Countries
5.1 North America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
5.2 USA Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
5.3 Canada Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
5.4 Mexico Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6 Europe Cell Therapy and Tissue Engineering Revenue by Countries
6.1 Europe Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
6.2 Germany Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.3 UK Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.4 France Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.5 Russia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.6 Italy Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cell Therapy and Tissue Engineering Revenue by Countries
7.1 Asia-Pacific Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
7.2 China Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.3 Japan Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.4 Korea Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.5 India Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
8 South America Cell Therapy and Tissue Engineering Revenue by Countries
8.1 South America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
8.2 Brazil Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
8.3 Argentina Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
8.4 Colombia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cell Therapy and Tissue Engineering by Countries
9.1 Middle East and Africa Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.3 UAE Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.4 Egypt Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.6 South Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
10 Global Cell Therapy and Tissue Engineering Market Segment by Type
10.1 Global Cell Therapy and Tissue Engineering Revenue and Market Share by Type (2014-2019)
10.2 Global Cell Therapy and Tissue Engineering Market Forecast by Type (2019-2024)
10.3 Cell Therapy Revenue Growth Rate (2014-2024)
10.4 Tissue Engineering Revenue Growth Rate (2014-2024)
11 Global Cell Therapy and Tissue Engineering Market Segment by Application
11.1 Global Cell Therapy and Tissue Engineering Revenue Market Share by Application (2014-2019)
11.2 Cell Therapy and Tissue Engineering Market Forecast by Application (2019-2024)
11.3 Cell Defects Revenue Growth (2014-2019)
11.4 Genetic Diseases Revenue Growth (2014-2019)
11.5 Neurodegenerative Diseases Revenue Growth (2014-2019)
11.6 Tissue Malignancies Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Cell Therapy and Tissue Engineering Market Size Forecast (2019-2024)
12.1 Global Cell Therapy and Tissue Engineering Market Size Forecast (2019-2024)
12.2 Global Cell Therapy and Tissue Engineering Market Forecast by Regions (2019-2024)
12.3 North America Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.4 Europe Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.6 South America Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cell Therapy and Tissue Engineering Picture
Table Product Specifications of Cell Therapy and Tissue Engineering
Table Global Cell Therapy and Tissue Engineering and Revenue (Million USD) Market Split by Product Type
Figure Global Cell Therapy and Tissue Engineering Revenue Market Share by Types in 2018
Figure Cell Therapy Picture
Figure Tissue Engineering Picture
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Application (2014-2024)
Figure Cell Therapy and Tissue Engineering Revenue Market Share by Applications in 2018
Figure Cell Defects Picture
Figure Genetic Diseases Picture
Figure Neurodegenerative Diseases Picture
Figure Tissue Malignancies Picture
Figure Others Picture
Table Global Market Cell Therapy and Tissue Engineering Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Table Betalin Therapeutics Basic Information, Manufacturing Base and Competitors
Table Betalin Therapeutics Cell Therapy and Tissue Engineering Type and Applications
Table Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table BioCardia, Inc Basic Information, Manufacturing Base and Competitors
Table BioCardia, Inc Cell Therapy and Tissue Engineering Type and Applications
Table BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table BioReliance Corporation Basic Information, Manufacturing Base and Competitors
Table BioReliance Corporation Cell Therapy and Tissue Engineering Type and Applications
Table BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Biosolution Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Type and Applications
Table Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Brainstorm Cell Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table MaxCyte, Inc Basic Information, Manufacturing Base and Competitors
Table MaxCyte, Inc Cell Therapy and Tissue Engineering Type and Applications
Table MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Medigene AG Basic Information, Manufacturing Base and Competitors
Table Medigene AG Cell Therapy and Tissue Engineering Type and Applications
Table Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table MEDIPOST CO., Ltd. Basic Information, Manufacturing Base and Competitors
Table MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Type and Applications
Table MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Mesoblast Limited Basic Information, Manufacturing Base and Competitors
Table Mesoblast Limited Cell Therapy and Tissue Engineering Type and Applications
Table Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Miromatrix Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table MolMed S.p.A Basic Information, Manufacturing Base and Competitors
Table MolMed S.p.A Cell Therapy and Tissue Engineering Type and Applications
Table MolMed S.p.A Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Mustang Bio, Inc Basic Information, Manufacturing Base and Competitors
Table Mustang Bio, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table NantKwest, Inc. Basic Information, Manufacturing Base and Competitors
Table NantKwest, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Neuralstem, Inc Basic Information, Manufacturing Base and Competitors
Table Neuralstem, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table NexImmune, Inc. Basic Information, Manufacturing Base and Competitors
Table NexImmune, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Nohla Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table ReNeuron Group plc Basic Information, Manufacturing Base and Competitors
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Type and Applications
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Richter-Helm BioLogics GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Type and Applications
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoosterBio, Inc Basic Information, Manufacturing Base and Competitors
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Type and Applications
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoslinCT Basic Information, Manufacturing Base and Competitors
Table RoslinCT Cell Therapy and Tissue Engineering Type and Applications
Table RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Rubius Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Voyager Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Type and Applications
Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table WindMIL Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Wuxi App Tec, Inc. Basic Information, Manufacturing Base and Competitors
Table Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table ReNeuron Group plc Basic Information, Manufacturing Base and Competitors
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Type and Applications
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Richter-Helm BioLogics GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Type and Applications
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoosterBio, Inc Basic Information, Manufacturing Base and Competitors
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Type and Applications
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoslinCT Basic Information, Manufacturing Base and Competitors
Table RoslinCT Cell Therapy and Tissue Engineering Type and Applications
Table RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Players (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue Share by Players (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Players in 2017
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Players in 2018
Figure Global Top 5 Players Cell Therapy and Tissue Engineering Revenue Market Share in 2018
Figure Global Top 10 Players Cell Therapy and Tissue Engineering Revenue Market Share in 2018
Figure Global Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Regions (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue Market Share by Regions (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Market Share by Regions (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Market Share by Regions in 2018
Figure North America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Europe Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure South America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table North America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
Table North America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure North America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure North America Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure USA Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Canada Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Mexico Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Europe Cell Therapy and Tissue Engineering Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Europe Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure Germany Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure UK Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure France Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Russia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Italy Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cell Therapy and Tissue Engineering Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure China Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Japan Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Korea Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure India Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table South America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
Table South America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure South America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure South America Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure Brazil Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Argentina Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Colombia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cell Therapy and Tissue Engineering Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure UAE Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Egypt Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Nigeria Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure South Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Type (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue Share by Type (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Type (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Type in 2018
Table Global Cell Therapy and Tissue Engineering Revenue Forecast by Type (2019-2024)
Figure Global Cell Therapy and Tissue Engineering Market Share Forecast by Type (2019-2024)
Figure Global Cell Therapy Revenue Growth Rate (2014-2019)
Figure Global Tissue Engineering Revenue Growth Rate (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue by Application (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue Share by Application (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Application (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Application in 2018
Table Global Cell Therapy and Tissue Engineering Revenue Forecast by Application (2019-2024)
Figure Global Cell Therapy and Tissue Engineering Market Share Forecast by Application (2019-2024)
Figure Global Cell Defects Revenue Growth Rate (2014-2019)
Figure Global Genetic Diseases Revenue Growth Rate (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Growth Rate (2014-2019)
Figure Global Tissue Malignancies Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cell Therapy and Tissue Engineering Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
Figure Europe Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
Figure South America Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
自家細胞療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is t…- 初代細胞培養の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Primary Cell Culture market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also…
- 細胞療法市場：世界及び中国市場分析・予測（～2024年） Cell Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cell Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cell Therapy manufacturers and is a valuable…
- 幹細胞治療市場：世界及び中国市場分析・予測（～2024年） Stem Cell Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Stem Cell Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Stem Cell Therapy manufacturers an…
- 骨関節炎用幹細胞治療市場：世界及び中国市場分析・予測（～2024年） Stem Cell Therapy for Osteoarthritis Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Stem Cell Therapy for Osteoarthritis industry with a focus on the Chinese market. The report provides key statistics on the market status of …